Aldesulfone sodium: Difference between revisions

Aldesulfone sodium
Clinical data
Routes of; administration	Oral
ATC code	J04BA03 (WHO) ;
Pharmacokinetic data
Protein binding	69%
Metabolism	Hepatic
Elimination half-life	3 to 8 hours
Identifiers
	IUPAC name [4-[4-(sulfinomethylamino) phenyl] sulfonylphenyl] aminomethanesulfinic acid;
CAS Number	144-75-2 ;
PubChem CID	8954;
DrugBank	APRD00704 ;
ChemSpider	8610 ;
UNII	57OWB0Q221;
KEGG	D02521 ;
ChEMBL	ChEMBL1200580 ;
CompTox Dashboard (EPA)	DTXSID9023623 ;
Chemical and physical data
Formula	C14H16N2O6S3
Molar mass	404.485 g/mol g·mol−1
3D model (JSmol)	Interactive image;
	SMILES [Na+].[Na+].[O-]S(=O)CNc1ccc(cc1)S(=O)(=O)c2ccc(NCS([O-])=O)cc2;
	InChI InChI=1S/C14H16N2O6S3.2Na/c17-23(18)9-15-11-1-5-13(6-2-11)25(21,22)14-7-3-12(4-8-14)16-10-24(19)20;;/h1-8,15-16H,9-10H2,(H,17,18)(H,19,20);;/q;2*+1/p-2 ; Key:AZBNFLZFSZDPQF-UHFFFAOYSA-L ;
	(what is this?) (verify)

Content deleted Content added

Inline

Revision as of 19:43, 13 January 2012

Aldesulfone sodium (or sulfoxone) is an antibiotic used in the treatment of leprosy.

Sulfoxone sodium was introduced in Japan in 1948.^[1]

^ "[A 50-year history of new drugs in Japan: the developments of antileprosy drugs and their epidemiological aspects]". Yakushigaku Zasshi. 37 (1): 76–83. 2002. PMID 12412600.

This antiinfective drug article is a stub. You can help Wikipedia by expanding it.

@@ Line 1: / Line 1: @@
 {{Drugbox
 | Verifiedfields = changed
-| verifiedrevid = 456677956
+| verifiedrevid = 470455608
 | IUPAC_name = [4-[4-(sulfinomethylamino) phenyl] sulfonylphenyl] aminomethanesulfinic acid
 | image = Aldesulfonesodium.png